Use of ultrasound to early identify, diagnose and localize metastases in melanoma patients

Expert Review of Anticancer Therapy

Volumn 7, Issue 12, 2007, Pages 1707-1716

  Schäfer Hesterberg, Gregor ^a   Schoengen, Alfred ^b   Sterry, Wolfram ^a   Voit, Christiane ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Federal Armed Forces   (Germany)

Author keywords

Cytology; Fine needle aspiration; FNAC; Follow up examination; Lymph node; Melanoma; Non invasive; Sentinel node; SLND; Sonography; Ultrasound

Indexed keywords

ALBUMIN TC 99M;

ARTICLE; ASPIRATION BIOPSY; ATHEROMA; B SCAN; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIPOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SEROMA; SKIN TUMOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR VASCULARIZATION; TUMOR VOLUME;

BIOPSY, FINE-NEEDLE; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; ULTRASONOGRAPHY;

EID: 37349098357     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.7.12.1707     Document Type: Article

References (49)

1. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int. J. Cancer 92, 457-462 (2001).
2. Marks R. Epidemiology of melanoma. Clin. Exp. Dermatol. 25, 459-463 (2000).
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide (Version 1.0). LARC Cancer Base No. 5. IARC Press, Lyon, France (2001).
4. Fusi S, Aryian S, Stemlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population. Plast. Reconstr Surg. 91, 94-98 (1993).
5. Urist MM, Balch CM, Soong S et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55, 1398-1402 (1985).
6. Ames FC, Balch CM, Reintgen C. Local recurrences and their management. In: Cutaneous Melanoma (2nd Edition). Balch CM, Houghton AN, Miltron GW et al. (Eds). JB Lippincott, PA, USA 287-294 (1992).
7. Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol. Surg. 21, 285-290 (1995).
8. Voit C, Mayer T, Kron M et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91, 2409-2416 (2001).
9. Cascinelli N, Bufalino R, Marolda R et al. Regional non-nodal metastases of cutaneous melanoma. Eur. Surg. Oncol. 12, 175-180 (1986).
10. Krag DN, Meijer SJ, Weaver DL et al. Minimal access surgery for staging malignant melanoma. Arch. Surg. 130, 654-658 (1995).
11. Albertini JJ, Cruse CW, Rappaport D et al. Intraoperative radiolymphoscintigraphy improves sentinel node identification for patients with melanoma. Ann. Surg. 223, 217-224 (1996).
12. Balch CM, Buzaid CA, Atkins MB et al. A New American Joint Committee on cancer staging system for cutaneous melanoma. Cancer 88, 1484-1491 (2000).
13. Miller EJ, Daly JM, Synnestvedt M, Schultz D, Elder D, Guerry D IV. Loco-regional nodal relapse in melanoma. Surg. Oncol. 1, 333-40 (1992).
14. Buzaid AC, Tinoco LA, Jendiroba D et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J. Clin. Oncol. 9, 2361-2368 (1995).
15. Prayer L, Winkelbauer H, Gritzmann N, Winkelbauer F, Helmer M, Pehamberger H. Sonography versus palpation in the detection of regional lymph node metastases in patients with malignant melanoma. Eur. J. Cancer 7, 827-830 (1990).
16. Binder M, Kittler H, Steiner A, Dorffner R, Wolff K, Pehamberger H. Lymph node sonography versus palpation for detection of recurrent disease in patients with malignant melanoma. Eur. J. Cancer 33, 1805-1808 (1997).
17. Nazarian LN, Alexander AA, Rawool NM, Kurtz AB, Maguire HC, Mastrangelo MJ. Malignant melanoma: impact of superficial US on mangement. Radiology 199, 273-277 (1996).
18. Rossi CR, Seno A, Vecchiato A et al. The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur. J. Cancer 33, 200-203 (1997).
19. Voit C, Mayer T, Proebstle TM et al. Ultrasound guided fine needle aspiration cytology (FNAC) in the early detection of melanoma metastases. Cancer 90, 186-193 (2000).
20. Pellacani G, Seidenari S. Preoperative melanoma thickness determination by 20-MHz sonography and digital videomicroscopy in combination. Arch. Dermatol. 139, 293-298 (2003).
21. Tacke J, Haagen G, Hornstein OP et al. Clinical relevance of sonometry-derived tumour thickness in malignant melanoma - a statistical analysis. Br. J. Dermatol. 132, 209-214 (1995).
22. Gambichler T, Moussa G, Babrenberg K et al. Preoperative ultrasonic assessment of thin melanocytic skin lesions using a 100-MHz ultrasound transducer: a comparative study. Dermatol. Surg. 33, 818-824 (2007).
23. Lassau N, Lamuraglia M, Koscielny S et al. Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5-year follow-up period. Cancer Imaging 25, 24-29 (2006).
24. Jemec GBE, Gniadecka M, Ulrich J. Ultrasound in dermatology. Part 1. High frequency ultrasound. Eur. J. Dermatol. 10, 492-497 (2000).
25. Dill-Müller D, Maschke J. Ultrasonography in dermatology. J. Duch. Dermatol. Ges. 5, 689-707 (2007).
26. Vasallo P. Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high resolution US. Radiology 183, 215-220 (1992).
27. Alexander AA, Nazarian LN, Capuzzi DM Jr, Rawool NW, Kurtz AB, Mastrangelo MJ. Color Doppler sonographic detection of tumor flow in superficial melanoma metastases: histologic correlation. J. Ultrasound Med. 17, 123-126 (1998).
28. Nazarian LN, Alexander AA, Kurtz AB et al. Superficial melanoma metastases: appearances on gray-scale and color doppler sonography. Am. J. Roentgenol. 170, 459-463 (1998).
29. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous disease. Cancer 88, 2534-2539 (2000).
30. Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 5, 673-680 (2004).
31. Ulrich J, Voit C. Ultrasound in dermatology. Part II. Ultrasound of regional lymph node basins and subcutaneous tumours. Eur. J. Dermatol. 11, 73-79 (2001).
32. Ulrich J, Gollnick H. Differential diagnosis of cutaneous and subcutaneous tumours assessed by 7.5 MHz ultrasonography, J. Eur. Acad. Dermatol. Venereol. 12, 187-189 (1999).
33. Voit C, Proebstle TM, Winter H et al. Presurgical ultrasound-guided anchor-wire marking of soft tissue metastases in stage III melanoma patients. Derm. Surg. 27, 129-132 (2001).
34. Dalle S, Paulin C, Lapras V, Balme B, Ronger-Savle S, Thomas L. Fine-needle aspiration biopsy with ultrasound guidance in patients with malignant melanoma and palpable lymph nodes. Br. J. Dermatol. 155, 552-556 (2006).
35. Binder T. Feinnadelaspirationszytologie: verbesserte Punktionstechnik mit einem neuen Aspirationsgerät. Tumor Diagnostik Therapie 8, 36-39 (1987).
36. Murali R, Doubrovsky A, Watson GF et al. Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. Am. J. Clin. Pathol. 127, 385-397 (2007).
37. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127, 392-399 (1992).
38. McMasters KM, Reintgen DS, Ross MI et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J. Clin. Oncol. 19, 2851-2855 (2001).
39. Morton DL, Thompson JF, Cochran AJ et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355, 1307-1317 (2006).
40. Doubrovsky A, de Wilt JH, Scolyer RA, McCarthy WH, Thompson JF. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann. Surg. Oncol. 11, 829-836 (2004).
41. Eggermont AM. Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodes. Ann. Surg. Oncol. 12, 3-5 (2005).
42. Voit C, Kron M, Schafer G et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann. Surg. Oncol. 13, 1682-1689 (2006).
43. Voit CA, van Akkooi ACJ, Schaefer-Hesterberg G, Schoengen A, Sterry W, Eggermont AMM. Role of ultrasound (US) and US-guided fine needle aspiration cytology (US-FNAC) prior to sentinel lymph node biopsy (SLNB) in 500 melanoma patients: reduction of need for SLND by high US-FNAC SN positive identification rate. J. Clin. Oncol. 25(Suppl. 18), 8512 (2007).
44. Machet L, Nemeth-Normand F, Giraudeau B et al. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients. Br. J. Dermatol. 152, 66-70 (2005).
45. Autier P, Coebergh JW, Boniol M, Doré JF, de Vries E, Eggermont AMM. Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated. J. Clin. Oncol. 21, 3707 (2003).
46. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol. 22, 3345-3349 (2004).
47. van Akkooi AC, de Wilt JH, Verhoef C et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann. Oncol. 17, 1578-1585 (2006).
48. Riker AI, Panelli MC, Kammula US et al. Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma. Cancer Detect. Prev. 23, 387-396 (1999).
49. Fetsch PA, Steinberg SM, Riker AI, Marincola FM, Abati A. Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials: a preliminary look, Cancer 93, 409-414 (2001).